insights_auto
Why is TMCI down 12.52%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$4.61
arrow_downward
-12.52%(-0.66) 1D
ኖቬም 16, 3:17:40 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$5.23
High
US$5.36
Low
US$4.43
Mkt. cap
302.23 ሚ
Avg. vol.
298.58 ሺ
Volume
252.26 ሺ
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
Open
US$5.23
High
US$5.36
Low
US$4.43
Mkt. cap
302.23 ሚ
Avg. vol.
298.58 ሺ
Volume
252.26 ሺ
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
News stories
From web sources and news partners
ChartMill
·
ከ1 ሰዓት በፊት
Today's Most-Active S&P 500 Stocks: Ford Leads Volume as SMCI and Micron Fall
Investor's Business Daily
·
ከ1 ሰዓት በፊት
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
Yahoo Finance
·
ከ1 ሰዓት በፊት
The S&P 500’s shot at 4 straight double-digit years is in Nvidia’s hands
The Korea Times
·
ከ2 ሰዓቶች በፊት
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc